Pathogen genomics in healthcare: overcoming barriers to proactive surveillance

被引：0
|
作者：
Sundermann, Alexander J. [1 ,2 ]
Rosa, Rossana [3 ]
Harris, Patrick N. A. [4 ,5 ,6 ]
Snitkin, Evan [7 ,8 ]
Javaid, Waleed [9 ]
Moore, Nicholas M. [10 ]
Hayden, Mary K. [10 ]
Allen, Krisandra [11 ]
Rodino, Kyle [12 ]
Peacock, Sharon J. [13 ]
Abbo, Lilian M. [3 ,14 ,15 ]
Harrison, Lee H. [1 ,2 ,16 ]
机构：
[1] Univ Pittsburgh, Ctr Genom Epidemiol, Microbial Genom Epidemiol Lab, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA
[3] Jackson Hlth Syst, Infect Prevent & Control Program, Miami, FL USA
[4] Univ Queensland, Fac Med, Ctr Clin Res, Herston, Qld, Australia
[5] QLD Hlth, Herston Infect Dis Inst, Metro North, Herston, Qld, Australia
[6] Royal Brisbane & Womens Hosp, Cent Microbiol, Pathol Queensland, Herston, Australia
[7] Univ Michigan, Med Sch, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
[8] Univ Michigan, Med Sch, Dept Internal Med, Div Infect Dis, Ann Arbor, MI USA
[9] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY USA
[10] Rush Univ, Dept Internal Med, Med Ctr, Chicago, IL USA
[11] Digital Technol Inc, Coralville, IA USA
[12] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA
[13] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge, England
[14] Univ Miami, Div Infect Dis, Miller Sch Med, Miami, FL USA
[15] Univ Miami, Miami Transplant Inst, Miller Sch Med, Miami, FL USA
[16] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2025年 / 69卷 / 01期
关键词：
genomic epidemiology; surveillance; outbreaks; infection prevention;
D O I：
10.1128/aac.01479-24
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Pathogen genomic surveillance in healthcare has the potential to enhance patient safety by detecting outbreaks earlier, thereby reducing morbidity and mortality. Despite benefits, there are barriers to adoption, including cost, expertise, and lack of standardized methodologies and incentives. This commentary advocates for 1) investment from healthcare payors, public health, and regulatory bodies and 2) additional research on genomic surveillance for improving patient outcomes and reducing infections. Effective implementation will require strategic investment and cross-sector collaboration.
引用
收藏
页数：13
相关论文
共 50 条
12345